Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695820016 | Nafarelin (as nafarelin acetate) 200 microgram/actuation nasal spray | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3759848016 | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46713601000001116 | Nafarelin 200micrograms/dose nasal spray | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing nafarelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Nafarelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Nafarelin acetate preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Nafarelin acetate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Synthetic hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Substance with gonadotropin mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing nafarelin acetate in nasal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Nasal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing nafarelin in nasal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has basis of strength substance | Nafarelin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has precise active ingredient | Nafarelin acetate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing only nafarelin in nasal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Nasal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Nasal route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutionspray.nasal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Nafarelin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Nafarelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Nafarelin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has specific active ingredient | Nafarelin acetate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has dispensed dose form | Spray dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has basis of strength substance | Nafarelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nafarelin 200micrograms nasal spray - product | Is a | False | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Synarel 200micrograms/actuation nasal spray (Pfizer Ltd) | Is a | True | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Nafarelin 200micrograms/actuation nasal spray 60 dose | Is pack of | False | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Nafarelin 200micrograms/actuation nasal spray 30 dose | Is pack of | False | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Nafarelin 200micrograms/actuation nasal spray 60 dose | Has VMP | True | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Nafarelin 200micrograms/actuation nasal spray 30 dose | Has VMP | True | Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR